1. Home
  2. BOLT vs REBN Comparison

BOLT vs REBN Comparison

Compare BOLT & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • REBN
  • Stock Information
  • Founded
  • BOLT 2015
  • REBN 2015
  • Country
  • BOLT United States
  • REBN United States
  • Employees
  • BOLT N/A
  • REBN N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • BOLT Health Care
  • REBN Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • REBN Nasdaq
  • Market Cap
  • BOLT 11.5M
  • REBN 13.3M
  • IPO Year
  • BOLT 2021
  • REBN 2022
  • Fundamental
  • Price
  • BOLT $4.75
  • REBN $1.65
  • Analyst Decision
  • BOLT Buy
  • REBN
  • Analyst Count
  • BOLT 4
  • REBN 0
  • Target Price
  • BOLT $34.00
  • REBN N/A
  • AVG Volume (30 Days)
  • BOLT 20.9K
  • REBN 81.4K
  • Earning Date
  • BOLT 11-14-2025
  • REBN 11-14-2025
  • Dividend Yield
  • BOLT N/A
  • REBN N/A
  • EPS Growth
  • BOLT N/A
  • REBN N/A
  • EPS
  • BOLT N/A
  • REBN N/A
  • Revenue
  • BOLT $4,167,000.00
  • REBN $6,565,623.00
  • Revenue This Year
  • BOLT N/A
  • REBN $335.98
  • Revenue Next Year
  • BOLT N/A
  • REBN N/A
  • P/E Ratio
  • BOLT N/A
  • REBN N/A
  • Revenue Growth
  • BOLT N/A
  • REBN 14.03
  • 52 Week Low
  • BOLT $4.59
  • REBN $1.03
  • 52 Week High
  • BOLT $13.80
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 35.12
  • REBN 23.44
  • Support Level
  • BOLT $5.65
  • REBN $2.14
  • Resistance Level
  • BOLT $5.93
  • REBN $2.37
  • Average True Range (ATR)
  • BOLT 0.35
  • REBN 0.13
  • MACD
  • BOLT -0.14
  • REBN -0.04
  • Stochastic Oscillator
  • BOLT 0.00
  • REBN 2.25

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: